Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 292

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Assessment of Growth Hormone Dynamics in Human Immunodeficiency Virus-Related Lipodystrophy1

Rietschel, Petra, Hadigan, Colleen, Corcoran, Colleen, Stanley, Takara, Neubauer, Gregory, Gertner, Joseph, Grinspoon, Steven·2001·The Journal of Clinical Endocrinology & Metabolism

Abstract

Human immunodeficiency virus (HIV) lipodystrophy (LIPO) is characterized by increased visceral adiposity, peripheral fat atrophy, dyslipidemia, and insulin resistance. GH concentrations are known to vary inversely with excess weight and body fat but have not been investigated in HIV lipodystrophy. Twenty-one subjects with HIV LIPO, 20 HIV-infected nonlipodystrophy subjects (NONLIPO), and 20 control (C) subjects were prospectively recruited for this study and compared. Subjects in the three groups were all male, age-matched [median, 47 yr old (interquartile range, 37–50) LIPO; 41 (37–44) NONLIPO; and 43 (37–49) C], and body mass index-matched [median, 24.3 kg/m2 (interquartile range, 22.2–26.6) LIPO; 24.4 (23.3–25.9) NONLIPO; and 24.8 (22.7–26.1) C] (P> 0.05 for all comparisons). Visceral abdominal fat [16,124 mm2 (11,246–19,790) LIPO; 7,559 (5,134–11,201) NONLIPO; and 8,803 (6,165–11,623) C; P < 0.01 LIPO vs. NONLIPO and LIPO vs. C] and the ratio of visceral abdominal fat to sc abdominal fat [1.37 (0.71–2.44) LIPO vs. 0.57 (0.47–0.78) NONLIPO vs. 0.55 (0.41–0.71) C, P < 0.01 LIPO vs. NONLIPO and LIPO vs. C] were significantly increased in the LIPO subjects but were not significantly different between NONLIPO and C. The mean overnight GH concentration, determined from frequent sampling every 20 min (from 2000 h to 0800 h) was decreased in the LIPO subjects [0.38 μg/L (0.13–0.67) LIPO vs. 0.96 (0.53–1.30) NONLIPO vs. 0.81 (0.49–1.03) C, P < 0.05 LIPO vs. NONLIPO and LIPO vs. C] and not significantly different between NONLIPO and C. Pulse analysis demonstrated decreased baseline GH [0.08 μg/L (0.06–0.21) LIPO vs. 0.19 (0.10–0.32) NONLIPO vs. 0.17 (0.12–0.57) C, P < 0.05 LIPO vs. NONLIPO and LIPO vs. C] and GH peak amplitude [1.06μ g/L (0.46–1.94) LIPO vs. 2.47 (1.22–3.43) NONLIPO and 2.27 (1.36–4.25) C, P < 0.05 LIPO vs. NONLIPO and LIPO vs. C] in the LIPO subjects but no significant difference in pulse frequency. No significant differences were observed between NONLIPO and C for any GH parameter. Insulin-like growth factor-I was not different between the groups. Total body fat (r = −0.40, P = 0.01) and visceral fat (r = −0.58, P = 0.0001) correlated inversely with mean overnight GH concentrations in the HIV-infected patients. In a multivariate regression model, controlling for age, body mass index, body fat, and visceral fat, only visceral fat was a significant predictor of mean GH concentrations (P = 0.0036, r2 for model = 0.40). These data demonstrate normal GH pulse frequency and insulin-like growth factor-I concentrations but reduced mean GH concentrations, basal GH concentrations, and GH pulse amplitude in patients with HIV lipodystrophy. Increased visceral adiposity is the strongest predictor of reduced GH concentrations in HIV lipodystrophy. Further studies are necessary to determine the clinical significance of reduced GH in patients with HIV lipodystrophy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.86.2.7175

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 292

Metadata

Authors
Rietschel, P., Hadigan, C., Corcoran, C., Stanley, T., Neubauer, G., Gertner, J., & Grinspoon, S.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2001-02-01
Volume
86
Issue
2
Pages
504-510
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2120052316
Cited by
292
References
27
FWCI
16.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of Growth Hormone Dynamics in Human Immunodeficiency Virus-Related Lipodystrophy1. https://app.cochat.ai/papers/10.1210/jcem.86.2.7175
The paper
Rietschel, P., Hadigan, C., Corcoran, C., Stanley, T., Neubauer, G., Gertner, J., & Grinspoon, S. (2001). Assessment of Growth Hormone Dynamics in Human Immunodeficiency Virus-Related Lipodystrophy1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.86.2.7175

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.